Do you have a compact space that you'd like to make more stylish and functional? Here are ways Chip and Joanna Gaines have ...

A veteran apparently took their own life Jan. 27 at the parking garage at the VA Medical Center in Syracuse, New York, draped ...

Take a look at the official gameplay trailer for Playtable Games' Foxtale, a fantasy sci-fi adventure where players control a fox. Wuthering Waves teases the next part of its ongoing story with ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The firm expects the expansion to allow over 17,000 additional client orders annually. Credit: Jaguar Land Rover. UK’s luxury car manufacturer Jaguar Land Rover (JLR) has unveiled plans to ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

LAWRENCE, Kan. – With the first game at the reimagined David Booth Kansas Memorial Stadium seven months and one day away, the interior of the upgraded stadium is starting to come to life with detailed ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...